Loss of SMAD4, which occurs late in pancreatic tumorigenesis, promotes cancer cell proliferation and motility by the dysregulation of the TGF-β pathway, causing tumor chemoresistance, invasion and metastasis, immune evasion, etc. [98]. This evidence concerns the gene SMAD4 and neoplasm.